Medical Device | Healthcare | Biotechnology | Pharmaceuticals

The growth of neuromodulation market is driven majorly by the rising prevalence of neurological disorders, increasing research into expanding the applications of neuromodulation, and awareness on neurodegenerative disorders. However, the high cost of neuromodulation procedures and equipment, along with the dearth of a trained workforce, is expected to restrain the growth of this market during the forecast period. Neuromodulation Market Dynamics: Impact Analysis 1. Expansion in Emerging Economies 2. Rising Awareness on Neurodegenerative Disorders 3. Research into Expanding the Applications of Neuromodulation 4. Rising Prevalence of Neurological Disorders 5. Rising Incidence of Parkinson’s Disease The global  neuromodulation market  is projected to reach USD 8.8 billion by 2025 from USD 5.8 billion in 2020, at a CAGR of 8.6%. Key Questions Addressed in The Report: 1. Who are the top 10 players operating in the global Neuromodulation market? 2. What are the dri...

The global neuromodulation market is projected to reach USD 8.8 billion by 2025 from USD 5.8 billion in 2020, at a CAGR of 8.6%. The growth of this market is driven majorly by the rising prevalence of neurological disorders, increasing research into expanding the applications of neuromodulation, and awareness on neurodegenerative disorders. However, the high cost of neuromodulation procedures and equipment, along with the dearth of a trained workforce, is expected to restrain the growth of this market during the forecast period. Parkinson’s disease held the largest share of the deep brain stimulation market, by application Based on application, the deep brain stimulation market is segmented into Parkinson’s disease, tremor, depression, and other DBS applications. Parkinson’s disease accounted for the largest share of this market in 2019. The growth of this segment is attributed to the rising incidence of the disease and growing R&D activity in this area. Download PDF Brochu...